Cargando…
DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?
Major depressive disorder (MDD) is a debilitating psychiatric disorder, the third leading global cause of disability. Regarding aetiopathogenetic mechanisms involved in the onset of depressive disorders, the interaction between genetic vulnerability traits and environmental factors is believed to pl...
Autores principales: | Paoli, Caterina, Misztak, Paulina, Mazzini, Giulia, Musazzi, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890294/ https://www.ncbi.nlm.nih.gov/pubmed/35105292 http://dx.doi.org/10.2174/1570159X20666220201084536 |
Ejemplares similares
-
Involvement of miR-135a-5p Downregulation in Acute and Chronic Stress Response in the Prefrontal Cortex of Rats
por: Mingardi, Jessica, et al.
Publicado: (2023) -
Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia
por: Sowa-Kućma, Magdalena, et al.
Publicado: (2017) -
Mechanisms associated with post-stroke depression and pharmacologic therapy
por: Zhan, Qingyang, et al.
Publicado: (2023) -
Poststroke Depression Biomarkers: A Narrative Review
por: Levada, Oleg A., et al.
Publicado: (2018) -
Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease
por: Prell, Tino, et al.
Publicado: (2019)